A new strategy has been proposed to improve sensitivity of osteosarcoma cells to chemotherapy by inducing de-SUMOylation of connexin 43 (Cx43), a component of gap junctions, and increasing free Cx43 levels, important for recovery of normal cellular functions (Zhang et al., 2018). Here, GJA1 is linked to osteosarcoma.